Thu, May 23, 2013, 8:22 PM EDT - U.S. Markets closed
approval for SMD Cohort 2???
ACT Announces Data and Safety Monitoring Board (DSMB) Approval to Increase RPE Dosage for Stargardt’s Disease Patients in U.S. TrialDSMB Also Approves Treatment of Final Two Patients of First Cohort in E.U. Trial